Spectra for:
Ashutosh Banerjee, Roland Fr�hlich, Dirk Schepmann, Bernhard W�nsch
Compound 17A (+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL
![(+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL](/api/compound/6ZQPvbo0vBa.png?h=300&w=458 "(+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL")
Compound 17B (+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL
![(+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL](/api/compound/6zcFbcPpTp7.png?h=300&w=458 "(+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL")
Compound 17C (+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL
![(+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL](/api/compound/APNkb8yMtyQ.png?h=300&w=458 "(+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-OL")
Compound 19A (+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE
![(+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE](/api/compound/G5u0gMxJlh9.png?h=300&w=458 "(+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE")
Compound 19B (+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE
![(+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE](/api/compound/BTuNsPPOrx9.png?h=300&w=458 "(+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE")
Compound 19C (+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE
![(+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE](/api/compound/1Z27OfW1Y0S.png?h=300&w=458 "(+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE")
Compound 19D (+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE
![(+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE](/api/compound/4QsBmcO6Riz.png?h=300&w=458 "(+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-4-METHOXY-PIPERIDINE")
Compound 21A (+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE
![(+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE](/api/compound/DUFOvwOkGyB.png?h=300&w=458 "(+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE")
Compound 21B (+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE
![(+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE](/api/compound/7IC3poQOX4t.png?h=300&w=458 "(+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE")
Compound 21C (+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE
![(+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE](/api/compound/1cnV6AXA1hF.png?h=300&w=458 "(+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE")
Compound 21D (+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE
![(+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE](/api/compound/8ewP6NxaEVv.png?h=300&w=458 "(+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-PIPERIDIN-4-AMINE")
Compound 23A (+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE
![(+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE](/api/compound/KgigXnHBFMV.png?h=300&w=458 "(+/-)-(2RS,4SR)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE")
Compound 23B (+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE
![(+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE](/api/compound/HhnPrbfwavP.png?h=300&w=458 "(+/-)-(2RS,4RS)-2-[(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE")
Compound 23C (+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE
![(+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE](/api/compound/7hZpvzSeo8a.png?h=300&w=458 "(+/-)-(2RS,4SR)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE")
Compound 23D (+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE
![(+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE](/api/compound/AJS4l7iD1uL.png?h=300&w=458 "(+/-)-(2RS,4RS)-2-[(4RS)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-N-METHYLPIPERIDIN-4-AMINE")
#12C+#12A;MAJOR+MINOR;MIXTURE;(+/-)-(2RS)-1-(4-METHOXYBENZYL)-2-[(4RS)/(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-2,3-DIHYDROPYRIDIN-4(1H)-ONE
![#12C+#12A;MAJOR+MINOR;MIXTURE;(+/-)-(2RS)-1-(4-METHOXYBENZYL)-2-[(4RS)/(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-2,3-DIHYDROPYRIDIN-4(1H)-ONE](/api/compound/GxAcsFedfCm.png?h=300&w=458 "#12C+#12A;MAJOR+MINOR;MIXTURE;(+/-)-(2RS)-1-(4-METHOXYBENZYL)-2-[(4RS)/(4SR)-2,2-DIPHENYL-1,3-DIOXOLAN-4-YL]-2,3-DIHYDROPYRIDIN-4(1H)-ONE")
Citation
| Citation | MEDCHEMCOMM,1,87(2010) |
|---|---|
| Journal | MedChemComm |
| Issue | 1 |
| Volume | 1 |
| Page(s) | 87 |
| Year | 2010 |
| Author(s) | Ashutosh Banerjee, Roland Fr�hlich, Dirk Schepmann, Bernhard W�nsch |
| Publisher | Royal Society of Chemistry (RSC) |
| DOI | 10.1039/c0md00017e |